The following is a summary of “Development of antibody levels and subsequent decline in individuals with vaccine induced and hybrid immunity to SARS-CoV-2,” published in the September 2024 issue of ...

Innovative research has unveiled promising advancements in melanoma detection, which could significantly enhance diagnosis and prognosis by identifying the disease at its earliest, most treatable ...

This new method, presented at the European Academy of Dermatology and Venereology (EADV) Congress 2024, uses tumour-specific profiling to detect antibodies unique to stage I and II melanoma patients.

Amsterdam, Netherlands) Innovative research has unveiled promising advancements in melanoma detection, which could ...

The following is a summary of “Early, robust mucosal secretory IgA but not IgG response to SARS-CoV-2 spike in oral fluid is ...

Discover Genmab AS's groundbreaking patent for enhanced antibodies with a variant Fc domain, improving cancer treatment efficacy through innovative polypeptide technology.

Discover Agenus Inc.'s groundbreaking patent for TIM-3 targeting antibodies, detailing innovative therapeutic methods and potential applications in immunology and oncology.

IGM Biosciences has collaboration deal with Sanofi inked in 2022 and its stock has almost doubled in 2024 year to date. Read ...

One of the main sources of community- and hospital-acquired infections is Staphylococcus aureus, well known for its ...

Staphylococcus aureus, mostly known from its antibiotic-resistant variant Methicillin-resistant Staphylococcus aureus (MRSA), is among the leading causes of both community- and hospital-acquired ...

An international collaboration of researchers in Europe and the U.S. has identified a critical immune factor for host defense against Staphylococcus aureus, which could offer a potential explanation ...